Absci Corporation ABSI
9.74
(0.61)
(5.89%)
as of 25 Sep
- Market cap
- $1.8B
- P/E
- 0.0×
Follow ABSI
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(55.68%) | (62.50%) | (63.89%) | (57.72%) | |
| (47.73%) | (53.59%) | (55.34%) | (50.57%) | ||
ROIC |
(173.47%) | (163.37%) | (165.27%) | (174.74%) | |
Return on Tangible Assets |
(68.09%) | (78.00%) | (90.60%) | (58.95%) | |
Average Days of Receivables |
129.66 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.56) | (0.68) | (0.64) | (0.69) | |
Free Cash Flow |
(80.06) | (92.72) | (97.30) | (108.80) | |
Capital Expenditures |
0.65 | 0.21 | 0.09 | (0.71) | |
Piotroski F-Score |
3.00 | 3.00 | 3.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
(21.21%) | (27.77%) | (32.67%) | (24.16%) | |
Accounts Receivable Turnover |
5.39 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
2,644.69% | 2,907.79% | 4,593.08% | 5,540.49% | |
Selling, General and Administrative Expense of Revenue |
1,252.90% | 1,252.07% | 1,886.93% | 2,260.09% | |
Share Based Compensation of Revenue |
679.64% | 654.32% | 968.85% | 1,170.79% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.70 | 0.81 | 0.82 | 0.89 | |
Depreciation/Fixed assets |
0.53 | 0.56 | 0.61 | 0.66 | |
Capex/Depreciation |
0.05 | 0.02 | 0.01 | (0.06) | |
Revenue per Share |
0.02 | 0.02 | 0.01 | 0.01 | |
Operating CF per Share |
(0.56) | (0.68) | (0.64) | (0.69) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
(0.23) | (0.07) | (0.05) | 0.46 | |
Net Profit Margin |
(4,071.19%) | (4,113.68%) | (6,450.76%) | (7,756.37%) |
Columns are period end dates